News | December 19, 2014

Two Guidelines Added to ACC Guideline Clinical App

App provides mobile access to guidelines, tools for treatment, prevention of heart disease

Atrial fibrillation, heart valve repair, software, mobile devices, ACC app

December 19, 2014 — The American College of Cardiology’s recently released Guideline Clinical App has expanded with the addition of tools and guideline content for two conditions, valvular heart disease and atrial fibrillation.

The ACC Guideline Clinical App was launched in November with the initial version including content based on guidelines for heart failure, cardiovascular risk assessment and treatment of blood cholesterol. In addition to the Executive Summary and Top 10 Points for each guideline, the app includes a collection of interactive tools such as dosing calculators, scoring tools and algorithms useful to clinicians in determining recommended care.

The ACC, which has been developing clinical practice guidelines in partnership with the American Heart Association for more than three decades, developed this app to serve as a mobile home for all ACC/AHA guideline content and related tools.

The ACC will continue to refine and expand the app. An additional update is expected in March with content and tools based on guidelines for the treatment of obesity and the management of lifestyle to reduce cardiovascular risk.

The American College of Cardiology Guideline Clinical App is available for free on iTunes and GooglePlay.

For more information: www.acc.org

 

Related Content

Edwards LifeSciences Recalls Sapien 3 Certitude Delivery System
News | Heart Valve Technology| January 11, 2018
The U.S. Food and Drug Administration (FDA) announced that Edwards LifeSciences is recalling its Certitude Delivery...
Videos | Heart Valve Technology| January 04, 2018
Adam Greenbaum, M.D., co-director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, explains how hi
Edwards Acquires Harpoon Medical
News | Heart Valve Technology| December 07, 2017
December 7, 2017 — Edwards Lifesciences Corp.
Videos | Heart Valve Technology| November 15, 2017
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, is the principal investigato
New Analyses Reinforce Hemodynamic Benefits of Evolut TAVR Platform in Intermediate-Risk Aortic Stenosis Patients
News | Heart Valve Technology| November 08, 2017
Medtronic plc recently presented new clinical research to support the positive clinical performance of the Evolut...
Videos | Heart Valve Technology| November 08, 2017
Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents the
Videos | Heart Valve Technology| November 08, 2017
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morris
Harpoon Mitral Valve Repair System data reported at TCT 2017
Feature | Heart Valve Technology| November 07, 2017
November 7, 2017 – A new study has found that a pioneering device to repair heart valves is safe and effective, and c
Videos | Heart Valve Technology| November 07, 2017
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, explains the current state o
Overlay Init